BACKGROUND: Converging evidence suggests that immune-mediated dysfunction plays an important role in the pathogenesis of frontotemporal dementia (FTD). Although genetic studies have shown that immune-associated loci are associated with increased FTD risk, a systematic investigation of genetic overlap between immune-mediated diseases and the spectrum of FTD-related disorders has not been performed. CONCLUSIONS: We show immune-mediated genetic enrichment specifically in FTD, particularly within the HLA region. Our genetic results suggest that for a subset of patients, immune dysfunction may contribute to FTD risk. These findings have potential implications for clinical trials targeting immune dysfunction in patients with FTD.

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies / Broce, I., Karch, C.M., Wen, N., Fan, C.C., Wang, Y., Tan, C.H., Kouri, N., Ross, O.A., Höglinger, G.U., Muller, U., Hardy, J., Momeni, P., Hess, C.P., Dillon, W.P., Miller, Z.A., Bonham, L.W., Rabinovici, G.D., Rosen, H.J., Schellenberg, G.D., Franke, A., et al.. - In: PLOS MEDICINE. - ISSN 1549-1277. - ELETTRONICO. - 15:(2018), pp. e1002487-0. [10.1371/journal.pmed.1002487]

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

Nacmias, B;Sorbi, S;Bagnoli, S;Piaceri, I;
2018

Abstract

BACKGROUND: Converging evidence suggests that immune-mediated dysfunction plays an important role in the pathogenesis of frontotemporal dementia (FTD). Although genetic studies have shown that immune-associated loci are associated with increased FTD risk, a systematic investigation of genetic overlap between immune-mediated diseases and the spectrum of FTD-related disorders has not been performed. CONCLUSIONS: We show immune-mediated genetic enrichment specifically in FTD, particularly within the HLA region. Our genetic results suggest that for a subset of patients, immune dysfunction may contribute to FTD risk. These findings have potential implications for clinical trials targeting immune dysfunction in patients with FTD.
2018
15
e1002487
0
Broce, Iris; Karch, Celeste M; Wen, Natalie; Fan, Chun C; Wang, Yunpeng; Tan, Chin Hong; Kouri, Naomi; Ross, Owen A; Höglinger, Günter U; Muller, Ulri...espandi
File in questo prodotto:
File Dimensione Formato  
journal.pmed.1002487.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 4.02 MB
Formato Adobe PDF
4.02 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1112683
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 118
social impact